Wu, Jian
Liu, Wei
Zhu, Sirui
Liu, Hongyi
Chen, Kezhe
Zhu, Yingting
Li, Zhidong
Yang, Chenlong
Pan, Lijie
Li, Ruyue
Lin, Caixia
Tian, Jiaxin
Ren, Jiaoyan
Xu, Liangzhi
Yu, Hanxiang
Luo, Fagao
Huang, Zhiwei
Su, Wenru
Wang, Ningli
Zhuo, Yehong
Funding for this research was provided by:
National Natural Science Foundation of China (82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057, 82171057)
Article History
Received: 7 August 2022
Accepted: 25 January 2023
First Online: 7 February 2023
Declarations
:
: This study complied with the National Institutes of Health Guide for the Care and the guidelines of the Association for Research of Vision and Ophthalmology for the Use of Animal in Ophthalmic and Vision Research. The study was approved by the Ethical Committee of the Guangzhou Huazhen Biosciences Company (Ethics Number: 2020–168) and Zhongshan Ophthalmic Center (Permit Number: SYXK (YUE) 2018–0189). All methods are reported in accordance with ARRIVE guidelines for the reporting of animal experiments.
: Not applicable.
: The authors declare no competing interests.